CVS Health Corporation (NYSE:CVS) Shares Sold by PFG Investments LLC

PFG Investments LLC lessened its holdings in CVS Health Corporation (NYSE:CVS - Free Report) by 29.7% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,333 shares of the pharmacy operator's stock after selling 8,186 shares during the quarter. PFG Investments LLC's holdings in CVS Health were worth $1,310,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of the company. McIlrath & Eck LLC boosted its position in CVS Health by 32.6% during the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after acquiring an additional 174 shares during the last quarter. Coppell Advisory Solutions LLC boosted its position in CVS Health by 17.3% during the 4th quarter. Coppell Advisory Solutions LLC now owns 1,282 shares of the pharmacy operator's stock worth $56,000 after acquiring an additional 189 shares during the last quarter. EagleClaw Capital Managment LLC boosted its position in CVS Health by 3.4% during the 4th quarter. EagleClaw Capital Managment LLC now owns 6,135 shares of the pharmacy operator's stock worth $275,000 after acquiring an additional 200 shares during the last quarter. Angeles Investment Advisors LLC boosted its position in CVS Health by 3.7% during the 4th quarter. Angeles Investment Advisors LLC now owns 5,706 shares of the pharmacy operator's stock worth $256,000 after acquiring an additional 204 shares during the last quarter. Finally, Beck Mack & Oliver LLC boosted its position in CVS Health by 1.1% during the 4th quarter. Beck Mack & Oliver LLC now owns 20,425 shares of the pharmacy operator's stock worth $917,000 after acquiring an additional 232 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company's stock.

CVS Health Stock Down 0.2%

CVS opened at $66.69 on Friday. CVS Health Corporation has a 1-year low of $43.56 and a 1-year high of $72.51. The stock's fifty day simple moving average is $64.92 and its 200 day simple moving average is $60.42. The company has a current ratio of 0.82, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. The stock has a market cap of $84.36 billion, a PE ratio of 15.92, a price-to-earnings-growth ratio of 0.95 and a beta of 0.56.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, beating analysts' consensus estimates of $1.62 by $0.63. The business had revenue of $94.59 billion for the quarter, compared to analysts' expectations of $93.07 billion. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. The firm's revenue for the quarter was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.31 EPS. As a group, research analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on CVS shares. Robert W. Baird upped their price target on CVS Health from $51.00 to $71.00 and gave the stock a "neutral" rating in a research report on Tuesday, April 15th. Cowen reissued a "buy" rating on shares of CVS Health in a report on Monday, May 5th. Wells Fargo & Company reissued an "overweight" rating and issued a $84.00 price objective (up previously from $76.00) on shares of CVS Health in a report on Tuesday, May 6th. Royal Bank Of Canada increased their price objective on CVS Health from $74.00 to $81.00 and gave the company an "outperform" rating in a report on Monday, May 5th. Finally, Mizuho increased their price objective on CVS Health from $70.00 to $76.00 and gave the company an "outperform" rating in a report on Wednesday, April 9th. Two research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $74.75.

Insiders Place Their Bets

In other news, Director Guy P. Sansone acquired 1,570 shares of the stock in a transaction on Thursday, June 5th. The shares were purchased at an average price of $63.70 per share, for a total transaction of $100,009.00. Following the transaction, the director now directly owns 12,007 shares of the company's stock, valued at approximately $764,845.90. This represents a 15.04% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.22% of the company's stock.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.